Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.5 USD | +0.81% | -3.05% | +15.15% |
May. 31 | Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival | RE |
May. 31 | Sector Update: Health Care | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.15% | 315B | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B | |
-0.45% | 160B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- UBS Adjusts Merck & Co.'s Price Target to $148 From $135, Maintains Buy Rating